LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company, today announced continued advancement of its mobile healthcare application ecosystem, with applications being prepared for anticipated future availability through the Apple App Store and Google Play Store. The company also revealed that early-stage platform subscribers have surpassed 1,000, a milestone management believes reflects growing engagement with its healthcare technology ecosystem.
The applications under development are intended to support telehealth, healthcare communication, patient engagement, provider coordination, emergency response, and AI-assisted healthcare initiatives as part of the company's broader digital healthcare infrastructure strategy for emerging markets, particularly Latin America. Management stated that certain applications are being prepared for submission to Apple and Google following continued development, internal testing, platform review, and regulatory considerations.
Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., stated: "We are continuing to advance development of our mobile healthcare application ecosystem with the goal of expanding accessibility and healthcare connectivity through both Apple and Android mobile platforms. Surpassing 1,000 early-stage users represents an encouraging milestone as we continue refining and expanding our broader digital healthcare infrastructure initiatives."
The company emphasized that the applications remain under active development and have not yet been fully commercialized or broadly deployed. No assurance can be provided regarding the timing of any public release, App Store or Google Play availability, regulatory progression, or operational success. For more information, visit https://latamed.ai or review the company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.
The milestone of 1,000 subscribers is significant for a development-stage company, indicating early validation of its platform concept. Continued user growth could provide valuable operational feedback to refine functionality and prioritize features. LataMed AI's focus on underserved markets where healthcare coordination and digital tools are limited positions it to address critical gaps in healthcare access. However, the company faces risks common to early-stage ventures, including the need for financing, regulatory approvals, and successful commercial deployment.
LataMed AI Corp. is a development-stage digital health and AI technology company focused on scalable telehealth infrastructure and healthcare analytics platforms for emerging markets, with an initial emphasis on Latin America. The company is advancing a technology-enabled healthcare ecosystem designed to support remote patient engagement, provider coordination, healthcare analytics, emergency response integration, and broader digital healthcare delivery initiatives. Through telehealth infrastructure development, AI-driven technologies, regulatory progression initiatives, strategic partnerships, and operational expansion, LataMed AI is positioning itself to participate in the digital transformation of healthcare delivery systems across emerging markets.
This press release contains forward-looking statements regarding the company's business strategy, application development, Google Play Store availability, commercialization, regulatory progression, and future operations. These statements are based on current expectations and are subject to significant risks and uncertainties. Actual results may differ materially due to factors including the company's ability to implement its business plan, obtain financing, secure regulatory authorizations, and complete application development. The company undertakes no obligation to update forward-looking statements except as required by law.
